Recent studies show the effectiveness of DL-alpha-difluoromethylornithine (DFMO), a drug that blocks ODC and the production of polyamines, in suppressing polyamine synthesis, thereby inhibiting cell proliferation, especially in neuroblastoma and colorectal cancer51–53. This evidence concerns the gene ODC1 and medical procedure.